to assess the tolerance, security and effectiveness in the treatment of different intraocular inflammatory disease two years [clinicaltrials_resource:db1d0d8b4741423422a0a9b3d646283e]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
to assess the tolerance, security and effectiveness in the treatment of different intraocular inflammatory disease two years [clinicaltrials_resource:db1d0d8b4741423422a0a9b3d646283e]
Bio2RDF identifier
db1d0d8b4741423422a0a9b3d646283e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:db1d0d8b4741423422a0a9b3d646283e
measure [clinicaltrials_vocabulary:measure]
to assess the tolerance, secur ...... traocular inflammatory disease
time frame [clinicaltrials_vocabulary:time-frame]
identifier
clinicaltrials_resource:db1d0d8b4741423422a0a9b3d646283e
title
to assess the tolerance, secur ...... inflammatory disease two years
@en
type
label
to assess the tolerance, secur ...... d0d8b4741423422a0a9b3d646283e]
@en